During a unique in person event on the 9th of April 2024 in Dusseldorf, our team will present the unique Johnson & Johnson Innovation external collaboration model ranging from incubation and custom R&D collaborations to company co-creation and investment.

We will also host a session on how we see the partnering journey for early-stage innovators. Groundbreaking science, adequate funding, IP protection and a stellar team are all key ingredients in starting up a healthcare company. However, collaboration with a large corporate partner may also be critical to successfully bring your innovation to patients. Such a partnership or collaboration may bring you access to expertise, resources and networks that are otherwise hard to tap into. In this session, our team will share insights on how they evaluate opportunities, and discuss the steps involved in striking a deal and building a partnership or collaboration. We’ll explore how startups might set themselves up for success in early business development and become partner-ready faster.

The event will be hosted by Johnson & Johnson Innovation in collaboration with BioRiver and other local life sciences organizations. We look forward to meet innovative emerging companies and start-ups, as well as researchers, academics and organizations based in the broader NRW region and active in the Pharmaceutical and MedTech sectors.

Read more here.